Major arrhythmias in non-dilated left ventricular cardiomyopathy: a novel prediction score

European Heart Journal

18 July 2025
Organised by: Logo
ESC Journals ARRHYTHMIAS AND DEVICE THERAPY VALVULAR, MYOCARDIAL, PERICARDIAL, PULMONARY, CONGENITAL HEART DISEASE Myocardial Disease

Abstract

AbstractBackground and Aims

The prediction of the first major arrhythmic event (MAE) is still an unmet need in the recently defined scenario of non-dilated left ventricular cardiomyopathy (NDLVC).

Methods

A cohort of 337 patients with NDLVC and no history of MAE was retrospectively identified at two large centres. Patient-tailored diagnostic workup included cardiac magnetic resonance (CMR), endomyocardial biopsy, and genetic testing. The primary endpoint was the occurrence of the first MAE, including sustained ventricular tachycardia (VT), ventricular fibrillation, or appropriate implantable cardioverter-defibrillator therapy, by 60-month follow-up. A pool of 216 NDLVC patients from 11 European centres served as a validation cohort.

Results

In the study cohort (mean age 37 ± 15 years, 62% male), the mean left ventricular ejection fraction (LVEF) was 52 ± 8%, and 79% of patients had late gadolinium enhancement (LGE) at baseline CMR. By 60-month follow-up, 51 patients (15%) experienced a MAE. The primary endpoint was predicted by male sex [hazard ratio (HR) 2.4, 95% confidence interval (CI) 1.3–4.4, P = .007], baseline non-sustained VT (HR 3.1, 95% CI 1.7–5.6, P < .001), LVEF < 45% (HR 5.5, 95% CI 2.7–11.0, P < .001), septal (HR 2.0, 95% CI 1.0–4.0, P = .046) and ring-like pattern of LGE (HR 1.3, 95% CI .6–2.6, P = .54), pathogenic/likely pathogenic variants in guideline-defined high-risk genes (HR 4.6, 95% CI 2.3–9.1, P < .001), and biopsy/CMR-proven myocardial inflammation (HR 15.7, 95% CI 6.1–40.3, P < .001). The results were confirmed in the validation cohort (Uno’s C-index 0.81, 95% CI .75–.88). A novel risk score was subsequently derived.

Conclusions

In NDLVC, male sex, non-sustained VT, LVEF < 45%, septal and ring-like LGE, high-risk genotypes, and myocardial inflammation predicted the first episode of MAE by 60 months.

Contributors

Giovanni Peretto
Giovanni Peretto

Author

IRCCS San Raffaele Scientific Institute Milan , Italy

Andrea Villatore
Andrea Villatore

Author

IRCCS San Raffaele Scientific Institute Milan , Italy

Michael Spartalis
Michael Spartalis

Author

National & Kapodistrian University of Athens Athens , Greece

Alessia Paldino
Alessia Paldino

Author

Giuliano Isontina University Health Authority Trieste , Italy

Davide Lazzeroni
Davide Lazzeroni

Author

Don Carlo Gnocchi Onlus Foundation Parma , Italy

Raimondo Pittorru
Raimondo Pittorru

Author

Hospital Clinic, University of Barcelona Barcelona , Spain

Iacopo Olivotto
Iacopo Olivotto

Author

University of Florence Florence , Italy

Cristina Basso
Cristina Basso

Author

University of Padua Padova , Italy

Bettina Heidecker
Bettina Heidecker

Author

Charite University Hospital Berlin , Germany

Stephane Heymans
Stephane Heymans

Author

Cardiovascular Research Institute Maastricht (CARIM) Maastricht , Netherlands (The)

Gianfranco Sinagra
Gianfranco Sinagra

Author

University of Trieste Trieste , Italy

ESC 365 is supported by